Page last updated: 2024-08-23

paroxetine and Panic Attacks

paroxetine has been researched along with Panic Attacks in 141 studies

Research

Studies (141)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	31 (21.99)	18.2507
2000's	75 (53.19)	29.6817
2010's	29 (20.57)	24.3611
2020's	6 (4.26)	2.80

Authors

Authors	Studies
Guo, W; Han, Y; Li, H; Li, P; Liu, F; Shan, X; Xie, G; Yan, H	1
Barbui, C; Bighelli, I; Caldwell, DM; Cipriani, A; Davies, SJ; Dawson, S; Dias, S; Furukawa, TA; Guaiana, G; Imai, H; Koesters, M; Meader, N; Pompoli, A; Robertson, L; Tajika, A	1
Bianchi, L; Del Duca, E; Esposito, M; Fargnoli, MC; Giunta, A; Manfreda, V; Troisi, A	1
Bhatia, MS; Daral, A; Goyal, S; Singh, A	1
Gulpers, B; Hendriks, GJ; Kampman, M; Oude Voshaar, R; VAN Alphen, S; Verhey, F	1
Chen, L; Diao, Y; Du, B; Du, Y; Li, J; Shu, Y; Yin, Z; Zhang, Z	1
Amrein, R; Arias-Carrión, O; Carta, MG; Dias, GP; Freire, RC; Machado, S; Mochcovitch, MD; Nardi, AE; Versiani, M	1
Coimbra, JPC; Coimbra, NC; de Freitas, RL; Dos Anjos-Garcia, T; Falconi-Sobrinho, LL; Laure, CJ; Paschoalin-Maurin, T	1
Das, N; Garg, K; Kumar, CN	1
Gopalakrishnan, A; Kumar, PNS	1
Barbui, C; Bighelli, I; Breilmann, J; Castellazzi, M; Cipriani, A; Davies, SJ; Furukawa, TA; Girlanda, F; Guaiana, G; Koesters, M	1
Dupuis, G; Fleet, R; Lessard, MJ; Marchand, A; Pelland, ME; Poirier-Bisson, J; Roberge, P	1
Baltes, BB; Grekin, ER; Kirsch, I; Loree, AM; Sugarman, MA	1
Heo, JY; Jeon, HJ; Oh, JY; Song, H; Yoo, I; Yu, BH	1
Cosci, F	1
Cumurcu, BE; Gul, IG; Karlidag, R; Turkoz, Y	1
Barlow, DH; Farchione, TJ; Gallagher, MW; Gorman, JM; Payne, LA; Shear, MK; White, KS; Woods, SW	1
Abadia, MC; Baker, G; Gil, L; Lara, N; Le Melledo, JM; Mailo, K; Perez-Parada, J; Van Ameringen, M	1
Bandelow, B; Broocks, A; Engel, K; Falkai, P; Hüther, G; Sprute, A; Wedekind, D	1
Andreescu, C; Begley, AE; Lenze, EJ; Mazumdar, S; Mulsant, BH; Reynolds, CF; Wetherell, JL	1
Akiyama, K; Hirokane, G; Inoue, Y; Morita, S; Saeki, Y; Saito, A; Shimoda, K; Ueda, M; Watanabe, T; Yamada, N	1
Kim, JH; Lee, EH; Yu, BH	1
Harada, T; Ishigooka, J; Sakamoto, K; Yamada, K	1
Cohen, LJ; Galynker, II; Prosser, JM; Steele, A; Yard, S	1
Oros, MM; Reynolds, GP; Yevtushenko, OO	1
Annerbrink, K; Eriksson, E; Hedner, J; Olsson, M	1
DeVeaugh-Geiss, AM; Gaynes, BN; Kroenke, K; Miller, WC; Sleath, B; West, SL	1
Broekman, TG; Hendriks, GJ; Hoogduin, CA; Kampman, M; Keijsers, GP; Oude Voshaar, RC; Verbraak, MJ	1
Boerner, RJ	1
Kang, EH; Kim, KJ; Lee, IS; Park, JE; Shim, HB; Yu, BH	1
Bandelow, B; Broocks, A; Engel, K; Neubert, K; Wedekind, D; Weiss, N	1
Mochcovitch, MD; Nardi, AE	1
Aprile, S; Cabrino, C; De Panfilis, C; Marchesi, C; Parenti, P	1
Audi, EA; Graeff, FG; Roncon, CM; Sela, VR; Zangrossi, H	1
Bacon, SL; Belleville, G; Chauny, JM; Foldes-Busque, G; Lavoie, KL; Lessard, MJ; Marchand, A; Pelland, MÈ; Poitras, J; Vadeboncoeur, A	1
Altamura, C; Bosi, MF; Buoli, M; Dell'osso, B	1
Matsumoto, H; Tamai, Y	1
Amrein, R; Crippa, JA; da Costa, RT; de Carvalho, MR; de Cerqueira, AC; de O E Silva, AC; de-Melo-Neto, VL; Dias, GP; Freire, RC; Hallak, JE; King, AL; Levitan, MN; Mezzasalma, MA; Mochcovitch, MD; Nardi, AE; Nascimento, I; Sardinha, A; Soares-Filho, GL; Valença, AM; Veras, AB; Versiani, M	1
Amrein, R; Crippa, JA; da Costa, RT; de Carvalho, MR; de Cerqueira, AC; de O e Silva, AC; de-Melo-Neto, VL; Dias, GP; Freire, RC; Hallak, JE; King, AL; Levitan, MN; Mezzasalma, MA; Nardi, AE; Nascimento, I; Sardinha, A; Soares-Filho, GL; Valença, AM; Veras, AB; Versiani, M	1
Hendriks, GJ; Hoogduin, CA; Kampman, M; Keijsers, GP; Oude Voshaar, RC	1
Akiyama, K; Hayashi, Y; Inoue, Y; Ishiguro, S; Kato, K; Saeki, Y; Saito, A; Shimoda, K; Ueda, M; Watanabe, T	1
Cassano, GB; Mula, M; Pini, S; Preve, M	1
Amrein, R; Crippa, JA; da Costa, RT; de Carvalho, MR; de Cerqueira, AC; de-Melo-Neto, VL; Dias, GP; E Silva, AC; Freire, RC; Hallak, JE; King, AL; Levitan, MN; Mezzasalma, MA; Mochcovitch, MD; Nardi, AE; Nascimento, I; Paes, F; Sardinha, A; Soares-Filho, GL; Valença, AM; Veras, AB; Versiani, M	1
Kollias, K; Konstantakopoulos, G; Nathanailidis, E; Oulis, P; Tsiamoura, M	1
Black, DW	1
Dannon, PN; Grunhaus, L; Iancu, I	1
Hendriks, GJ; Hoogduin, CA; Kampman, M; Keijsers, GP	1
Cowley, D; Katon, WJ; Roy-Byrne, P; Russo, J	1
Pearson Murphy, BE	1
Cowley, DS; Katon, WJ; Roy-Byrne, PP; Russo, J	1
Andreatini, R; Beijamini, V	1
Koga, M	1
Doyle, AL; Otto, MW; Peters, P; Pollack, MH; Simon, NM; Toshkov, F; Worthington, JJ	1
Doyle, AC; Pollack, MH	1
Rao, R; Yeragani, VK	1
Annerbrink, K; Bengtsson, F; Eriksson, E; Hedner, J; Olsson, M	1
Masuda, Y; Shimizu, T	1
Rao, R; Tancer, M; Uhde, T; Yeragani, VK	1
Amiaz, R; Dannon, PN; Grunhaus, L; Kotler, M; Lowengrub, K	1
Amering, M; Bankier, B; Berger, P; Holzinger, A; Katschnig, H; Sachs, G	1
Alkin, T; Bandelow, B; Behnke, K; Clary, CM; Goebel, C; Hendriks, GJ; Lenoir, S	1
Bellodi, L; Bertani, A; Caldirola, D; Di Pasquale, D; Migliarese, G; Perna, G	1
Carmassi, C; Cassano, GB; Ciapparelli, A; Dell'Osso, L; Lucacchini, A; Martini, C; Montali, M; Palego, L; Sbrana, S; Trincavelli, ML; Tuscano, D	1
Cohen, A; Dannon, PN; Grunhaus, L; Iancu, I; Kotler, M; Lowengrub, K	1
Andrews, G; Carter, R; Donnelly, M; Haby, MM; Heuzenroeder, L; Mihalopoulos, C; Rossell, R; Vos, T	1
Bellodi, L; Bertani, A; Caldirola, D; Cucchi, M; Di Pasquale, D; Migliarese, G; Perna, G	1
Chao, I	1
Kim, YR; Park, Q; Yu, BH	1
Aizawa, Y; Fujita, S; Hanawa, H; Hayashi, M; Kato, K; Kodama, M; Komura, S; Kondo, D; Minagawa, S; Ohno, Y; Okura, Y; Sato, A	1
Griez, E; Schruers, K	1
Ballenger, JC	1
Burnham, DB; Iyengar, MK; Perera, P; Sheehan, DV	1
Dannon, PN; Iancu, I; Kotler, M; Lowengrub, K	1
Cyranowski, JM; Fagiolini, A; Frank, E; Kupfer, DJ; Scott, J; Shear, MK; Swartz, H	1
Bellodi, L; Bussi, R; Di Bella, D; Favaron, E; Perna, G	1
Bergink, V; Westenberg, HG	1
Cantoni, A; Fontò, S; Giannelli, MR; Maggini, C; Marchesi, C	2
Kim, EJ; Yu, BH	1
Espa-Cervená, K; Houbová, P; Novák, T; Pasková, B; Prasko, J; Vyskocilová, J; Záleský, R	1
Campanella, D; Carano, A; Cicconetti, A; D'Amico, M; De Berardis, D; Ferro, FM; Gambi, F; La Rovere, R; Mancini, E; Peca, S; Penna, L; Salerno, RM; Sepede, G	1
Bhanji, NH; Chouinard, G; Kolivakis, T; Margolese, HC	1
Harada, K	1
Hogg, S; Jessa, M; Michan, L	1
Cantoni, A; De Panfilis, C; Fontò, S; Giannelli, MR; Maggini, C; Marchesi, C	1
Emilien, G; Gao, B; Koponen, H; Lepola, U; Pollack, MH; Salinas, E; Simon, NM; Tzanis, E; Whitaker, T; Worthington, JJ	1
Ayestarán, A; Carrera, M; García-Unzueta, MT; Herrán, A; Hoyuela, F; Ramírez, ML; Rodríguez-Cabo, B; Sierra-Biddle, D; Vázquez-Barquero, JL	1
Agius, M; Biocina-Martić, S; Dordević, V; Gruber, EN	1
Akiyama, K; Hirokane, G; Morita, S; Okawa, M; Saeki, Y; Shimoda, K; Ueda, M; Watanabe, T	1
Bakker, A; Dusseldorp, E; Spinhoven, P; van Balkom, AJ; van Dyck, R	1
Arbuzov, AL; Khurbatova, IG; Reznik, AM	1
Entsuah, R; Mangano, R; Pollack, M; Simon, NM; Tzanis, E; Zhang, Y	1
Miyaoka, H; Saito, M	1
Doruk, A; Gulsun, M; Ozsahin, A; Turkbay, T; Uzun, O	1
Barlow, DH; Gorman, JM; McHugh, RK; Otto, MW; Shear, MK; Woods, SW	1
Kang, EH; Kim, KJ; Lee, IS; Yu, BH	1
Cantoni, A; De Panfilis, C; Giannelli, MR; Maggini, C; Marchesi, C	1
Behnke, K; Borup, AL; Calberg, H; Christiansen, PE; Judge, R; Manniche, PM; Oehrberg, S; Ohrstrom, JK; Severin, B; Soegaard, J	1
Chartier, MJ; Delaney, SM; Hazen, AL; Kroft, CD; Stein, MB	1
Apostolopoulos, M; Burrows, GD; Judd, FK; Maguire, KP; Norman, TR	1
Iny, L; Luthe, L; Pecknold, JC; Ramdoyal, D	1
Faludi, G; Tekes, K; Tóthfalusi, L	1
Power, KG; Sharp, DM; Simpson, RJ	1
Beaulieu, S; Bélanger, C; Corin, E; Kin, NM; Larue, S; Leyton, M; Martial, J; Meaney, M; Nair, NP; Pecknold, J; Thavundayil, J	1
Harnett-Sheehan, K; Sheehan, DV	1
Landry, P; Roy, L	1
Bakker, A; Dunbar, G; Judge, R; Lecrubier, Y	1
Judge, R; Lecrubier, Y	1
Tielens, JA	1
Adamson, P; Groff, J; McLean, H; Miranda, R; Scarborough, A; Tucker, P; Williams, D	1
Gorman, JM	1
Ballenger, JC; Bushnell, W; Gergel, IP; Steiner, M; Wheadon, DE	1
Benfield, P; Gunasekara, NS; Noble, S	1
Dantendorfer, K; Maierhofer, D; Windhaber, J	1
Burnham, D; Gergel, I; Lydiard, RB; Steiner, M	1
Stein, MB	1
Davidson, JR	1
Baldwin, DS; Birtwistle, J	1
Bell, CJ; Malizia, AL; Nutt, DJ	1
Bell, C; Nutt, D	1
Bakker, A; Matser, D; Spinhoven, P; van Balkom, AJ; van Dyck, R	1
Carleborg, L; Hägg, S; Ohman, R; Spigset, O	1
Sheehan, DV	1
Igel, G; Jampala, VC; Kay, J; Sobelewski, E; Yeragani, VK	1
Cassano, GB; Dell'Osso, L; Giannaccini, G; Lucacchini, A; Marazziti, D; Palego, L; Placidi, GP; Rossi, A	1
Bakker, A; Spinhoven, P; van Balkom, AJ; van Dyck, R	1
González, E; Minguez, L; Sanguino, RM	1
Balon, R; Jampala, VC; Pohl, R; Ramesh, C; Srinivasan, K; Yeragani, VK	1
Chartier, MJ; Graham, R; Ron Norton, G; Stein, MB; Walker, JR	1
Arancio, C; Bellodi, L; Bertani, A; Caldirola, D; Perna, G	1
Akiskal, HS; Frare, F; Mata, B; Mengali, F; Perugi, G; Recchia, M; Serra, G; Toni, C; Vitale, B	1
Andriushchenko, AV; Bykov, SI; Grigor'evskikh, VS; Koliutskaia, EV; Kosinskiĭ, VP; Kostiukova, EG; Kozlovskiĭ, VL; Kuzavkova, MV; Mosolov, SN; Nuller, IuL; Pererva, IG; Smulevich, AB; Zelenina, EV	1
Bellodi, L; Bertani, A; Caldirola, D; Perna, G; Smeraldi, E	1
Masi, G; Mata, B; Millepiedi, S; Mucci, M; Perugi, G; Toni, C	1
Masuko, M; Tsuboi, K	1
Cowley, DS; Katon, W; Roy-Byrne, PP; Russo, J	1
Clary, CM; Colucci, SV; Grudzinski, AN; Miceli, RJ; Roy-Byrne, PP; Xu, Y	1
di Michele, F; Holsboer, F; Pasini, A; Romeo, E; Rupprecht, R; Ströhle, A; Yassouridis, A	1
Dewan, N; Evans, S; Hamilton, C; Liu, T; Storrow, A; Wulsin, L	1
Adrover, M; Argyropoulos, S; Bell, C; Forshall, S; Hood, S; Nash, J; Nutt, DJ; Rich, A	1

Reviews

22 review(s) available for paroxetine and Panic Attacks

Article	Year
Pharmacological treatments in panic disorder in adults: a network meta-analysis. The Cochrane database of systematic reviews, 2023, 11-28, Volume: 11 Topics: Adult; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Clomipramine; Clonazepam; Desipramine; Diazepam; Fluoxetine; Humans; Network Meta-Analysis; Panic Disorder; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride	2023
Comparative efficacy and acceptability of antidepressants and benzodiazepines for the treatment of panic disorder: A systematic review and network meta-analysis. Asian journal of psychiatry, 2021, Volume: 60 Topics: Adult; Antidepressive Agents; Benzodiazepines; Humans; Network Meta-Analysis; Panic Disorder; Paroxetine	2021
Benzodiazepines versus placebo for panic disorder in adults. The Cochrane database of systematic reviews, 2019, Mar-28, Volume: 3 Topics: Adult; Aged; Agoraphobia; Benzodiazepines; Buspirone; Humans; Imipramine; Middle Aged; Numbers Needed To Treat; Panic Disorder; Paroxetine; Patient Dropouts; Placebos; Propranolol; Randomized Controlled Trials as Topic; Remission Induction; Young Adult	2019
The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales. PloS one, 2014, Volume: 9, Issue:8 Topics: Antidepressive Agents, Second-Generation; Anxiety; Anxiety Disorders; Clinical Trials as Topic; Depression; Double-Blind Method; Humans; Panic Disorder; Paroxetine; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome	2014
[Anxiety disorders: diagnosis and therapy from the family physician's perspective]. MMW Fortschritte der Medizin, 2006, May-15, Volume: Spec no. 2 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Behavior Therapy; Cognitive Behavioral Therapy; Cyclohexanols; Diagnosis, Differential; Family Practice; Humans; Panic Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2006
Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies. Expert review of neurotherapeutics, 2010, Volume: 10, Issue:8 Topics: Citalopram; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Placebo Effect; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2010
[Panic disorder and agoraphobia]. Ryoikibetsu shokogun shirizu, 2003, Issue:38 Topics: Agoraphobia; Cognitive Behavioral Therapy; Diagnosis, Differential; Diagnostic and Statistical Manual of Mental Disorders; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Reference Standards; Selective Serotonin Reuptake Inhibitors	2003
Treatment of panic disorder: focus on paroxetine. Psychopharmacology bulletin, 2003,Spring, Volume: 37 Suppl 1 Topics: Antidepressive Agents, Second-Generation; Humans; Panic Disorder; Paroxetine	2003
Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder. The Australian and New Zealand journal of psychiatry, 2004, Volume: 38, Issue:8 Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Australia; Cost-Benefit Analysis; Cyclohexanols; Disability Evaluation; Humans; Imipramine; Mental Health Services; Panic Disorder; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride	2004
Remission rates in patients with anxiety disorders treated with paroxetine. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:12 Topics: Adolescent; Adult; Aged; Anxiety Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Obsessive-Compulsive Disorder; Panic Disorder; Paroxetine; Phobic Disorders; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome	2004
Paroxetine in panic disorder: clinical management and long-term follow-up. Expert review of neurotherapeutics, 2004, Volume: 4, Issue:2 Topics: Clinical Trials as Topic; Disease Management; Follow-Up Studies; Humans; Panic Disorder; Paroxetine; Time	2004
Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena. The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique, 2006,Winter, Volume: 13, Issue:1 Topics: Aged; Akathisia, Drug-Induced; Anxiety; Female; Humans; Panic Disorder; Paroxetine; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome	2006
The role of SSRIs in panic disorder. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 10 Topics: 1-Naphthylamine; Citalopram; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1996
The use of newer antidepressants for panic disorder. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 14 Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	1997
Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders. Drugs, 1998, Volume: 55, Issue:1 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Nausea; Obsessive-Compulsive Disorder; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	1998
Efficacy studies of paroxetine in panic disorder. Psychopharmacology bulletin, 1998, Volume: 34, Issue:2 Topics: Antidepressive Agents, Second-Generation; Humans; Panic Disorder; Paroxetine	1998
Medication treatments for panic disorder and social phobia. Depression and anxiety, 1998, Volume: 7, Issue:3 Topics: Antidepressive Agents, Tricyclic; Benzamides; Benzodiazepines; Citalopram; Clinical Trials as Topic; Clomipramine; Clonazepam; Dose-Response Relationship, Drug; Female; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Piperidines; Recurrence; Selective Serotonin Reuptake Inhibitors; Social Behavior Disorders	1998
The long-term treatment of panic disorder. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 8 Topics: Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Clomipramine; Cognitive Behavioral Therapy; Drug Administration Schedule; Follow-Up Studies; Humans; Long-Term Care; Panic Disorder; Paroxetine; Recurrence; Relaxation Therapy; Treatment Outcome	1998
The side effect burden associated with drug treatment of panic disorder. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 8 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Citalopram; Clonazepam; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	1998
Brain mechanisms of social anxiety disorder. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 17 Topics: Animals; Brain; Caffeine; Carbon Dioxide; Cholecystokinin; Dopamine; Fear; Fenfluramine; Humans; Panic Disorder; Paroxetine; Phobic Disorders; Piperazines; Rats; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin; Tomography, Emission-Computed	1998
Current concepts in the treatment of panic disorder. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 18 Topics: Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1999
[Panic disorder and antidepressants]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:8 Topics: Antidepressive Agents, Tricyclic; gamma-Aminobutyric Acid; Humans; Norepinephrine; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin	2001

Trials

62 trial(s) available for paroxetine and Panic Attacks

Article	Year
The Impact of Personality Pathology on Treatment Outcome in Late-life Panic Disorder. Journal of psychiatric practice, 2020, Volume: 26, Issue:3 Topics: Adolescent; Adult; Aged; Agoraphobia; Cognitive Behavioral Therapy; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality; Personality Disorders; Treatment Outcome; Young Adult	2020
A 6-Year Posttreatment Follow-up of Panic Disorder Patients: Treatment With Clonazepam Predicts Lower Recurrence Than Treatment With Paroxetine. Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:4 Topics: Adult; Clonazepam; Female; Follow-Up Studies; GABA Modulators; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Predictive Value of Tests; Prospective Studies; Recurrence; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Young Adult	2017
Incremental cost-effectiveness of pharmacotherapy and two brief cognitive-behavioral therapies compared with usual care for panic disorder and noncardiac chest pain. The Journal of nervous and mental disease, 2013, Volume: 201, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Chest Pain; Cognitive Behavioral Therapy; Cohort Studies; Cost-Benefit Analysis; Drug Costs; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Psychotherapy, Brief; Quebec; Young Adult	2013
SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL. Depression and anxiety, 2016, Volume: 33, Issue:5 Topics: Adult; Agoraphobia; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2016
Paroxetine-induced increase in LDL cholesterol levels. Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:7 Topics: Adult; Cholesterol; Cholesterol, LDL; Humans; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; Triglycerides	2009
Nocturnal urinary cortisol excretion over a randomized controlled trial with paroxetine vs. placebo combined with relaxation training or aerobic exercise in panic disorder. Current pharmaceutical design, 2008, Volume: 14, Issue:33 Topics: Adult; Combined Modality Therapy; Exercise; Female; Humans; Hydrocortisone; Male; Middle Aged; Panic Disorder; Paroxetine; Pituitary-Adrenal System; Placebos; Relaxation Therapy; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome; Young Adult	2008
High worry severity is associated with poorer acute and maintenance efficacy of antidepressants in late-life depression. Depression and anxiety, 2009, Volume: 26, Issue:3 Topics: Aged; Antidepressive Agents; Anxiety Disorders; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Factor Analysis, Statistical; Female; Humans; Male; Panic Disorder; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index	2009
A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study. BMC psychiatry, 2009, May-26, Volume: 9 Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Outcome Assessment, Health Care; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Risperidone; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Young Adult	2009
Depression and comorbid panic in primary care patients. Journal of affective disorders, 2010, Volume: 123, Issue:1-3 Topics: Adult; Comorbidity; Depressive Disorder; Female; Fluoxetine; Humans; Longitudinal Studies; Male; Middle Aged; Multicenter Studies as Topic; Panic Disorder; Paroxetine; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States	2010
A randomized controlled study of paroxetine and cognitive-behavioural therapy for late-life panic disorder. Acta psychiatrica Scandinavica, 2010, Volume: 122, Issue:1 Topics: Aged; Agoraphobia; Cognitive Behavioral Therapy; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	2010
A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2010, Volume: 11, Issue:7 Topics: Adult; Agoraphobia; Combined Modality Therapy; Comorbidity; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Pilot Projects; Relaxation Therapy; Running; Selective Serotonin Reuptake Inhibitors; Young Adult	2010
Efficacy of 2 interventions for panic disorder in patients presenting to the ED with chest pain. The American journal of emergency medicine, 2011, Volume: 29, Issue:9 Topics: Adult; Chest Pain; Cognitive Behavioral Therapy; Emergency Service, Hospital; Female; Humans; Male; Panic Disorder; Paroxetine; Psychotherapy, Brief; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	2011
Slow vs standard up-titration of paroxetine in the treatment of panic disorder: a prospective randomized trial. Psychiatry and clinical neurosciences, 2010, Volume: 64, Issue:6 Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index	2010
Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2011, Volume: 44, Issue:4 Topics: Adolescent; Adult; Agoraphobia; Clonazepam; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult	2011
Randomized, open naturalistic, acute treatment of panic disorder with clonazepam or paroxetine. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:2 Topics: Adolescent; Adult; Clonazepam; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Time Factors; Treatment Outcome; Young Adult	2011
Predictors of outcome of pharmacological and psychological treatment of late-life panic disorder with agoraphobia. International journal of geriatric psychiatry, 2012, Volume: 27, Issue:2 Topics: Age Factors; Age of Onset; Aged; Agoraphobia; Cognitive Behavioral Therapy; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Predictive Value of Tests; Regression Analysis; Selective Serotonin Reuptake Inhibitors	2012
A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:1 Topics: Adolescent; Adult; Anticonvulsants; Brazil; Clonazepam; Drug Therapy, Combination; Female; Humans; Interview, Psychological; Long-Term Care; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Prospective Studies; Retreatment; Selective Serotonin Reuptake Inhibitors; Young Adult	2012
Psychoeducation in panic disorder patients: effect of a self-information booklet in a randomized, masked-rater study. Depression and anxiety, 2002, Volume: 16, Issue:2 Topics: Adult; Female; Health Education; Humans; Male; Mental Health; Pamphlets; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Surveys and Questionnaires; Treatment Outcome	2002
A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:9 Topics: Agoraphobia; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Drug Administration Schedule; Humans; Panic Disorder; Paroxetine; Personality Inventory; Placebos; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Treatment Outcome	2002
Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder. Archives of general psychiatry, 2002, Volume: 59, Issue:12 Topics: Adult; Ambulatory Care; Combined Modality Therapy; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Patient Care Team; Patient Education as Topic; Primary Health Care; Psychiatry; Psychotherapy; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Washington	2002
Unemployment and emergency room visits predict poor treatment outcome in primary care panic disorder. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:4 Topics: Adult; Agoraphobia; Comorbidity; Emergency Services, Psychiatric; Female; Follow-Up Studies; Health Status; Humans; Income; Male; Middle Aged; Multivariate Analysis; Panic Disorder; Paroxetine; Patient Education as Topic; Primary Health Care; Probability; Regression Analysis; Severity of Illness Index; Social Class; Treatment Outcome; Unemployment; White People	2003
Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. Journal of psychopharmacology (Oxford, England), 2003, Volume: 17, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Clonazepam; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors	2003
Paroxetine decreases respiratory irregularity of linear and nonlinear measures of respiration in patients with panic disorder. A preliminary report. Neuropsychobiology, 2004, Volume: 49, Issue:2 Topics: Adult; Analysis of Variance; Entropy; Female; Humans; Linear Models; Male; Nonlinear Dynamics; Panic Disorder; Paroxetine; Posture; Reference Values; Respiration; Selective Serotonin Reuptake Inhibitors	2004
Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder. Journal of affective disorders, 2004, Volume: 80, Issue:1 Topics: Adult; Ambulatory Care; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Female; Humans; Male; Panic Disorder; Paroxetine; Personality Disorders; Phobic Disorders; Prognosis; Proportional Hazards Models; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2004
Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:3 Topics: Acute Disease; Adult; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	2004
Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study. Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:3 Topics: Adolescent; Adult; Analysis of Variance; Bronchial Hyperreactivity; Carbon Dioxide; Chi-Square Distribution; Double-Blind Method; Female; Humans; Male; Morpholines; Panic Disorder; Paroxetine; Reboxetine; Statistics, Nonparametric	2004
Three year naturalistic outcome study of panic disorder patients treated with paroxetine. BMC psychiatry, 2004, Jun-11, Volume: 4 Topics: Adult; Agoraphobia; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Obesity; Panic Disorder; Paroxetine; Prevalence; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Treatment Outcome; Weight Gain	2004
Comparison of the treatment with paroxetine and reboxetine in panic disorder: a randomized, single-blind study. Pharmacopsychiatry, 2004, Volume: 37, Issue:5 Topics: Adrenergic Uptake Inhibitors; Adult; Female; Humans; Male; Morpholines; Panic Disorder; Paroxetine; Psychometrics; Reboxetine; Selective Serotonin Reuptake Inhibitors; Single-Blind Method	2004
The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder. Journal of psychopharmacology (Oxford, England), 2004, Volume: 18, Issue:4 Topics: Adult; Agoraphobia; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Carbon Dioxide; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Patient Compliance; Thiazepines	2004
Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:1 Topics: Adult; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Panic Disorder; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2005
Metabotropic glutamate II receptor agonists in panic disorder: a double blind clinical trial with LY354740. International clinical psychopharmacology, 2005, Volume: 20, Issue:6 Topics: Adult; Anti-Anxiety Agents; Bridged Bicyclo Compounds; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Receptors, Metabotropic Glutamate; Selective Serotonin Reuptake Inhibitors	2005
The effect of pharmacotherapy on personality disorders in panic disorder: a one year naturalistic study. Journal of affective disorders, 2005, Volume: 89, Issue:1-3 Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalopram; Comorbidity; Female; Follow-Up Studies; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Assessment; Personality Disorders; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2005
Influence of personality disorder on the treatment of panic disorder--comparison study. Neuro endocrinology letters, 2005, Volume: 26, Issue:6 Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Disorders; Personality Inventory; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	2005
Olanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed-dose, open-label trial. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:1 Topics: Adult; Agoraphobia; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Humans; Male; Olanzapine; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure	2006
A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Depression and anxiety, 2007, Volume: 24, Issue:1 Topics: Adult; Agoraphobia; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Psychometrics; Quality of Life; Treatment Outcome; Venlafaxine Hydrochloride	2007
High plasma concentrations of paroxetine impede clinical response in patients with panic disorder. Therapeutic drug monitoring, 2007, Volume: 29, Issue:1 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Asian People; Azepines; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Hypnotics and Sedatives; Lorazepam; Male; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Regression Analysis; Sleep Initiation and Maintenance Disorders; Time Factors	2007
Which panic disorder patients benefit from which treatment: cognitive therapy or antidepressants? Psychotherapy and psychosomatics, 2007, Volume: 76, Issue:3 Topics: Adolescent; Adult; Antidepressive Agents; Clomipramine; Cognitive Behavioral Therapy; Female; Humans; Internal-External Control; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Psychometrics; Regression Analysis; Treatment Outcome	2007
[Clinical picture and treatment of panic disorder accompanied with generalized anxiety]. Voenno-meditsinskii zhurnal, 2007, Volume: 328, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Combined Modality Therapy; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Psychotherapy; Treatment Outcome	2007
A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. Psychopharmacology, 2007, Volume: 194, Issue:2 Topics: Abortion, Spontaneous; Administration, Oral; Adult; Affective Disorders, Psychotic; Cyclohexanols; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Panic Disorder; Paroxetine; Pregnancy; Pregnancy, Unplanned; Remission Induction; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2007
Cost-efficacy of individual and combined treatments for panic disorder. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:7 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cost-Benefit Analysis; Health Care Costs; Humans; Imipramine; Panic Disorder; Paroxetine; Treatment Outcome	2007
Effect of pharmacological treatment on temperament and character in panic disorder. Psychiatry research, 2008, Mar-15, Volume: 158, Issue:2 Topics: Adult; Anxiety; Character; Citalopram; Female; Follow-Up Studies; GABA Modulators; Humans; Lorazepam; Male; Panic Disorder; Paroxetine; Personality Disorders; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Temperament	2008
Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study. The British journal of psychiatry : the journal of mental science, 1995, Volume: 167, Issue:3 Topics: Adolescent; Adult; Aged; Denmark; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1995
Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study. Journal of psychiatry & neuroscience : JPN, 1995, Volume: 20, Issue:3 Topics: Adolescent; Adult; Agoraphobia; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Paroxetine; Patient Dropouts; Prospective Studies; Psychiatric Status Rating Scales	1995
Cardiovascular, neuroendocrine, and monoaminergic responses to psychological stressors: possible differences between remitted panic disorder patients and healthy controls. Biological psychiatry, 1996, Sep-01, Volume: 40, Issue:5 Topics: Adult; Biogenic Monoamines; Blood Platelets; Female; Hemodynamics; Humans; Hydrocortisone; Male; Neurosecretory Systems; Panic Disorder; Paroxetine; Personality Inventory; Psychiatric Status Rating Scales; Radioimmunoassay; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Stress, Psychological	1996
A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators. Acta psychiatrica Scandinavica, 1997, Volume: 95, Issue:2 Topics: Adolescent; Adult; Aged; Clomipramine; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1997
Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators. Acta psychiatrica Scandinavica, 1997, Volume: 95, Issue:2 Topics: Adolescent; Adult; Aged; Clomipramine; Double-Blind Method; Female; Humans; Long-Term Care; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1997
Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. The American journal of psychiatry, 1998, Volume: 155, Issue:1 Topics: Adult; Agoraphobia; Comorbidity; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	1998
Efficacy studies of paroxetine in panic disorder. Psychopharmacology bulletin, 1998, Volume: 34, Issue:2 Topics: Antidepressive Agents, Second-Generation; Humans; Panic Disorder; Paroxetine	1998
Double-blindness procedure did not mask giving of medication in panic disorder. Journal of affective disorders, 1999, Volume: 54, Issue:1-2 Topics: Clomipramine; Double-Blind Method; Humans; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1999
Effects of paroxetine on heart period variability in patients with panic disorder: a study of holter ECG records. Neuropsychobiology, 1999, Volume: 40, Issue:3 Topics: Adult; Electrocardiography, Ambulatory; Female; Fractals; Heart Rate; Humans; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	1999
Decreased platelet 3H-paroxetine binding in untreated panic disorder patients. Life sciences, 1999, Volume: 65, Issue:25 Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Blood Platelets; Cell Membrane; Female; Humans; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tritium	1999
Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:12 Topics: Adolescent; Adult; Aged; Agoraphobia; Clomipramine; Cognitive Behavioral Therapy; Comorbidity; Double-Blind Method; Female; Humans; Male; Medical Records; Middle Aged; Panic Disorder; Paroxetine; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome	1999
Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study. Psychiatry research, 2000, Jul-17, Volume: 94, Issue:3 Topics: Adolescent; Adult; Aged; Cognition; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2000
Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:2 Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Carbon Dioxide; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Multivariate Analysis; Panic Disorder; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline	1997
A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants. Pharmacopsychiatry, 2000, Volume: 33, Issue:4 Topics: Adult; Aged; Agoraphobia; Antidepressive Agents; Clomipramine; Demography; Female; Humans; Imipramine; Italy; Longitudinal Studies; Male; Middle Aged; Panic Disorder; Paroxetine; Patient Dropouts; Probability; Prospective Studies; Time Factors; Treatment Outcome	2000
[Clinical effect and tolerance of paxil (paroxetine) in management of panic disorders]. Terapevticheskii arkhiv, 2000, Volume: 72, Issue:10 Topics: Adult; Agoraphobia; Antidepressive Agents, Second-Generation; Female; Humans; Male; Panic Disorder; Paroxetine; Treatment Outcome	2000
A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study. Pharmacopsychiatry, 2001, Volume: 34, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Fear; Female; Humans; Male; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Single-Blind Method; Surveys and Questionnaires; Treatment Outcome	2001
Paroxetine in child and adolescent outpatients with panic disorder. Journal of child and adolescent psychopharmacology, 2001,Summer, Volume: 11, Issue:2 Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Female; Humans; Male; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales	2001
A randomized effectiveness trial of collaborative care for patients with panic disorder in primary care. Archives of general psychiatry, 2001, Volume: 58, Issue:9 Topics: Adult; Algorithms; Combined Modality Therapy; Continuity of Patient Care; Drug Administration Schedule; Female; Follow-Up Studies; Health Services Research; Humans; Interviews as Topic; Male; Outcome Assessment, Health Care; Panic Disorder; Paroxetine; Patient Satisfaction; Patient Selection; Primary Health Care; Psychiatric Status Rating Scales; Psychotherapy; Quality of Health Care; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index	2001
GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. The American journal of psychiatry, 2002, Volume: 159, Issue:1 Topics: Adult; Agoraphobia; Female; Follow-Up Studies; GABA-A Receptor Antagonists; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Pregnanolone; Receptors, GABA-A; Stereoisomerism; Treatment Outcome	2002
A randomized, controlled trial of panic disorder treatment initiation in an emergency department chest pain center. Annals of emergency medicine, 2002, Volume: 39, Issue:2 Topics: Adult; Chest Pain; Emergency Service, Hospital; Female; Humans; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	2002
Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine. Journal of psychopharmacology (Oxford, England), 2002, Volume: 16, Issue:1 Topics: Adult; Affect; Aged; Agoraphobia; Cross-Over Studies; Double-Blind Method; Female; Flumazenil; GABA Modulators; Hemodynamics; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Tryptophan	2002

Other Studies

58 other study(ies) available for paroxetine and Panic Attacks

Article	Year
Can the aberrant occipital-cerebellum network be a predictor of treatment in panic disorder? Journal of affective disorders, 2023, 06-15, Volume: 331 Topics: Brain; Brain Mapping; Cerebellum; Humans; Magnetic Resonance Imaging; Panic Disorder; Paroxetine	2023
Long-term safety and efficacy of secukinumab in patients with psoriasis and major psychiatric disorders: a case series. Postgraduate medicine, 2020, Volume: 132, Issue:2 Topics: Adult; Agoraphobia; Antibodies, Monoclonal, Humanized; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Lithium Carbonate; Male; Mental Disorders; Middle Aged; Nordazepam; Panic Disorder; Paroxetine; Psoriasis; Quetiapine Fumarate; Severity of Illness Index; Treatment Outcome; Valproic Acid	2020
COVID-19 Pandemic-Induced Panic Disorder. The primary care companion for CNS disorders, 2020, 04-30, Volume: 22, Issue:3 Topics: Adult; Betacoronavirus; Clonazepam; Coronavirus Infections; COVID-19; Humans; Male; Pandemics; Panic Disorder; Paroxetine; Pneumonia, Viral; SARS-CoV-2	2020
The Rodent-versus-wild Snake Paradigm as a Model for Studying Anxiety- and Panic-like Behaviors: Face, Construct and Predictive Validities. Neuroscience, 2018, 01-15, Volume: 369 Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety; Dose-Response Relationship, Drug; Elapidae; Escape Reaction; Limbic System; Male; Mesocricetus; Models, Animal; Panic; Panic Disorder; Paroxetine; Predatory Behavior; Proto-Oncogene Proteins c-fos	2018
Koro in panic disorder: Beyond a culture bound phenomena. Asian journal of psychiatry, 2018, Volume: 31 Topics: Adult; Antidepressive Agents, Second-Generation; Clonazepam; Culture; GABA Modulators; Humans; India; Koro; Male; Panic Disorder; Paroxetine	2018
Paroxetine induced galactorrhoea - A case report. Asian journal of psychiatry, 2018, Volume: 34 Topics: Adult; Female; Galactorrhea; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	2018
Plasma catecholamine levels before and after paroxetine treatment in patients with panic disorder. Psychiatry research, 2015, Feb-28, Volume: 225, Issue:3 Topics: Adult; Arousal; Dopamine; Epinephrine; Female; Humans; Male; Middle Aged; Norepinephrine; Panic Disorder; Paroxetine; Reference Values; Young Adult	2015
Well-Being Therapy in a Patient with Panic Disorder Who Failed to Respond to Paroxetine and Cognitive Behavior Therapy. Psychotherapy and psychosomatics, 2015, Volume: 84, Issue:5 Topics: Cognitive Behavioral Therapy; Female; Humans; Middle Aged; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Failure	2015
Ghrelin and lipid levels in panic disorder before and after treatment and their relationship with agoraphobia. Psychiatria Danubina, 2015, Volume: 27, Issue:3 Topics: Agoraphobia; Ghrelin; Humans; Lipids; Panic Disorder; Paroxetine	2015
Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder. European journal of clinical pharmacology, 2009, Volume: 65, Issue:7 Topics: Adult; Aged; Agoraphobia; Antidepressive Agents, Second-Generation; Asian People; Female; Genotype; Humans; Japan; Linear Models; Male; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Regression Analysis; Serotonin Plasma Membrane Transport Proteins; Severity of Illness Index; Time Factors; Young Adult	2009
Reliability and validity of the self-report version of the Panic Disorder Severity Scale in Korea. Depression and anxiety, 2009, Volume: 26, Issue:8 Topics: Adult; Aged; Agoraphobia; Antidepressive Agents, Second-Generation; Cross-Cultural Comparison; Female; Humans; Korea; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Psychometrics; Reproducibility of Results; Translating; Young Adult	2009
Aripiprazole augmentation for a patient with partial remission of panic disorder. Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:3 Topics: Adult; Agoraphobia; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Humans; Male; Panic Disorder; Paroxetine; Piperazines; Quinolones; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2009
Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism. Journal of affective disorders, 2010, Volume: 123, Issue:1-3 Topics: Adult; Alleles; Female; Genotype; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Polymorphism, Genetic; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult	2010
Acute and chronic treatment with serotonin reuptake inhibitors exert opposite effects on respiration in rats: possible implications for panic disorder. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:12 Topics: Animals; Drug Administration Schedule; Fluoxetine; Male; Panic Disorder; Paroxetine; Piperazines; Pyridines; Rats; Rats, Wistar; Respiration; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Synapses	2010
Platelet serotonin transporter function after short-term paroxetine treatment in patients with panic disorder. Psychiatry research, 2010, Apr-30, Volume: 176, Issue:2-3 Topics: Adult; Blood Platelets; Chi-Square Distribution; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Statistics, Nonparametric; Time Factors; Tritium	2010
Defense style in panic disorder before and after pharmacological treatment. Psychiatry research, 2011, May-30, Volume: 187, Issue:3 Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety; Checklist; Citalopram; Defense Mechanisms; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Surveys and Questionnaires	2011
Pindolol potentiates the panicolytic effect of paroxetine in the elevated T-maze. Life sciences, 2010, Sep-25, Volume: 87, Issue:13-14 Topics: Adrenergic beta-Antagonists; Animals; Antidepressive Agents, Second-Generation; Anxiety Disorders; Drug Combinations; Drug Interactions; Male; Panic Disorder; Paroxetine; Pindolol; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors	2010
11-year-old boy with panic disorder responding to paroxetine. The Tokai journal of experimental and clinical medicine, 2007, Mar-20, Volume: 32, Issue:1 Topics: Alprazolam; Anti-Anxiety Agents; Child; Humans; Male; Neuropsychological Tests; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	2007
Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorder. European journal of clinical pharmacology, 2011, Volume: 67, Issue:12 Topics: Adult; Aged; Asian People; Female; Genotype; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Young Adult	2011
Venlafaxine in somatopsychic and autopsychic depersonalization. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Dec-01, Volume: 35, Issue:8 Topics: Agoraphobia; Cyclohexanols; Depersonalization; Depressive Disorder; Humans; Male; Obsessive Behavior; Panic Disorder; Paroxetine; Retreatment; Selective Serotonin Reuptake Inhibitors; Trimipramine; Venlafaxine Hydrochloride; Young Adult	2011
Low-dose aripiprazole in the treatment of selective serotonin reuptake inhibitors-induced orofacial and buccal dystonia. Psychiatry and clinical neurosciences, 2012, Volume: 66, Issue:5 Topics: Adult; Agoraphobia; Antipsychotic Agents; Aripiprazole; Dystonia; Face; Female; Humans; Panic Disorder; Paroxetine; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors	2012
Paroxetine for multiple chemical sensitivity syndrome. The American journal of psychiatry, 2002, Volume: 159, Issue:8 Topics: Adult; Comorbidity; Depressive Disorder; Female; Humans; Multiple Chemical Sensitivity; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2002
Neuroactive steroid levels in patients with panic disorder. The American journal of psychiatry, 2003, Volume: 160, Issue:3 Topics: Adult; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Menstrual Cycle; Panic Disorder; Paroxetine; Postmenopause; Pregnanolone; Pregnenolone; Progesterone; Radioimmunoassay; Research Design	2003
Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze. Pharmacological research, 2003, Volume: 48, Issue:2 Topics: Analysis of Variance; Animals; Anxiety; Avoidance Learning; Drug Administration Schedule; Hypericum; Male; Maze Learning; Panic; Panic Disorder; Paroxetine; Plant Extracts; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Swimming	2003
Effect of nortriptyline and paroxetine on measures of chaos of heart rate time series in patients with panic disorder. Journal of psychosomatic research, 2003, Volume: 55, Issue:6 Topics: Adult; Antidepressive Agents, Tricyclic; Arousal; Autonomic Nervous System; Electrocardiography; Female; Heart; Heart Rate; Humans; Long QT Syndrome; Male; Nonlinear Dynamics; Nortriptyline; Panic Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Signal Processing, Computer-Assisted	2003
Paroxetine influences respiration in rats: implications for the treatment of panic disorder. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2004, Volume: 14, Issue:1 Topics: Animals; Carbon Dioxide; Male; Panic Disorder; Paroxetine; Rats; Rats, Wistar; Respiration	2004
Different effects of selective serotonin reuptake inhibitors on a patient suffering from panic disorder. Human psychopharmacology, 2004, Volume: 19, Issue:1 Topics: Adult; Drug Therapy, Combination; Fluoxetine; Fluvoxamine; Humans; Hypnotics and Sedatives; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	2004
Comorbid cannabis use and panic disorder: short term and long term follow-up study. Human psychopharmacology, 2004, Volume: 19, Issue:2 Topics: Adolescent; Adult; Analysis of Variance; Chi-Square Distribution; Cohort Studies; Diagnosis, Dual (Psychiatry); Female; Follow-Up Studies; Humans; Male; Marijuana Abuse; Middle Aged; Panic Disorder; Paroxetine	2004
Serotonin-mediated cyclic AMP inhibitory pathway in platelets of patients affected by panic disorder. Neuropsychobiology, 2004, Volume: 50, Issue:1 Topics: Adult; Blood Platelets; Case-Control Studies; Cyclic AMP; Humans; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin	2004
Olanzapine augmentation in panic disorder: a case report. Pharmacopsychiatry, 2004, Volume: 37, Issue:5 Topics: Agoraphobia; Benzodiazepines; Drug Synergism; Drug Therapy, Combination; Humans; Male; Middle Aged; Olanzapine; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	2004
Changes in lymphocyte subsets after short-term pharmacotherapy in patients with panic disorder. Psychiatry research, 2004, Sep-30, Volume: 128, Issue:2 Topics: Adult; B-Lymphocyte Subsets; Drug Administration Schedule; Epinephrine; Female; Flow Cytometry; Humans; Immunophenotyping; Lymphocyte Count; Male; Norepinephrine; Panic Disorder; Paroxetine; Personality Inventory; Reference Values; Selective Serotonin Reuptake Inhibitors; T-Lymphocyte Subsets	2004
Life-threatening serotonin syndrome in a patient with chronic heart failure and CYP2D61/5. Mayo Clinic proceedings, 2004, Volume: 79, Issue:11 Topics: Adult; Chronic Disease; Cytochrome P-450 CYP2D6; Diagnosis, Differential; Electrocardiography; Heart Failure; Humans; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome	2004
Interpersonal psychotherapy for depression with panic spectrum symptoms: a pilot study. Depression and anxiety, 2005, Volume: 21, Issue:3 Topics: Anxiety Disorders; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Interpersonal Relations; Male; Panic Disorder; Paroxetine; Pilot Projects; Problem Solving; Psychotherapy; Quality of Life; Selective Serotonin Reuptake Inhibitors	2005
Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:12 Topics: Adult; Alleles; Antidepressive Agents, Second-Generation; Fear; Female; Gene Frequency; Genotype; Humans; Male; Panic Disorder; Paroxetine; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Reverse Transcriptase Polymerase Chain Reaction; Serotonin Plasma Membrane Transport Proteins; Surveys and Questionnaires	2005
Increased cholesterol levels after paroxetine treatment in patients with panic disorder. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:6 Topics: Adult; Case-Control Studies; Catecholamines; Cholesterol; Female; Humans; Male; Panic Disorder; Paroxetine; Psychological Tests; Selective Serotonin Reuptake Inhibitors	2005
Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study. Pharmacopsychiatry, 2006, Volume: 39, Issue:2 Topics: Adult; Agoraphobia; Anxiety Disorders; Citalopram; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Humans; Male; Panic Disorder; Paroxetine; Prospective Studies; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index	2006
Paroxetine-induced excessive yawning. Psychiatry and clinical neurosciences, 2006, Volume: 60, Issue:2 Topics: Adult; Drug Administration Schedule; Female; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Yawning	2006
Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety. Neuropharmacology, 2006, Volume: 51, Issue:1 Topics: Adrenergic alpha-Antagonists; Alprazolam; Animals; Anxiety; Citalopram; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Hypnotics and Sedatives; Male; Motor Activity; Panic Disorder; Paroxetine; Periaqueductal Gray; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stereotaxic Techniques; Yohimbine	2006
Personality disorders and response to medication treatment in panic disorder: a 1-year naturalistic study. Progress in neuro-psychopharmacology & biological psychiatry, 2006, Sep-30, Volume: 30, Issue:7 Topics: Adult; Antidepressive Agents, Second-Generation; Comorbidity; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality; Personality Inventory; Prospective Studies; Psychiatric Status Rating Scales	2006
Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:5 Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Citalopram; Female; Follow-Up Studies; Humans; Male; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2006
"My new Alfa Romeo GT is not in the garage any more": Cognitive behavioural therapy of panic disorder with agoraphobia co morbid with psychosis. Psychiatria Danubina, 2006, Volume: 18, Issue:3-4 Topics: Adult; Agoraphobia; Antipsychotic Agents; Atenolol; Benzodiazepines; Cognitive Behavioral Therapy; Combined Modality Therapy; Desensitization, Psychologic; Diazepam; Hospitalization; Humans; Male; Olanzapine; Panic Disorder; Paroxetine; Psychotic Disorders; Reality Testing; Socialization	2006
Augmentation of paroxetine with clocapramine in panic disorder. Psychiatry and clinical neurosciences, 2007, Volume: 61, Issue:4 Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Central Nervous System Stimulants; Dibenzazepines; Drug Therapy, Combination; Female; Humans; Panic Disorder; Paroxetine	2007
Effect of dissociative experiences on drug treatment of panic disorder. Clinical drug investigation, 2007, Volume: 27, Issue:8 Topics: Adult; Agoraphobia; Dissociative Disorders; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Regression Analysis; Selective Serotonin Reuptake Inhibitors	2007
beta-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder. Journal of affective disorders, 2008, Volume: 110, Issue:1-2 Topics: Acute Disease; Adult; Ambulatory Care; Biomarkers; Control Groups; Cyclic AMP; Female; Humans; Isoproterenol; Lymphocytes; Male; Panic Disorder; Paroxetine; Personality Inventory; Probability; Receptors, Adrenergic, beta; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2008
[3H]paroxetine binding to platelets of patients with social phobia: comparison to patients with panic disorder and healthy volunteers. Biological psychiatry, 1995, Feb-15, Volume: 37, Issue:4 Topics: Adult; Blood Platelets; Carrier Proteins; Female; Humans; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Panic Disorder; Paroxetine; Phobic Disorders; Radioligand Assay; Reference Values; Serotonin Plasma Membrane Transport Proteins	1995
Platelet [3H]paroxetine binding in panic disorder. Journal of affective disorders, 1995, Feb-21, Volume: 33, Issue:2 Topics: Adult; Analysis of Variance; Binding Sites; Blood Platelets; Female; Humans; Kinetics; Male; Panic Disorder; Paroxetine; Radioligand Assay; Tritium	1995
Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls. Journal of psychiatry & neuroscience : JPN, 1994, Volume: 19, Issue:2 Topics: Adult; Binding Sites; Biological Transport; Blood Platelets; Female; Humans; Imipramine; Male; Panic Disorder; Paroxetine; Serotonin	1994
Five group comparisons of treatments for anxiety disorders. The British journal of psychiatry : the journal of mental science, 1995, Volume: 167, Issue:6 Topics: Agoraphobia; Controlled Clinical Trials as Topic; Humans; Panic Disorder; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors	1995
Withdrawal hypomania associated with paroxetine. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Panic Disorder; Paroxetine; Substance Withdrawal Syndrome	1997
Vitamin C for paroxetine- and fluvoxamine-associated bleeding. The American journal of psychiatry, 1997, Volume: 154, Issue:6 Topics: Adult; Ascorbic Acid; Ecchymosis; Female; Fluvoxamine; Hemorrhage; Humans; Menorrhagia; Panic Disorder; Paroxetine	1997
Paroxetine increases heart rate variability in panic disorder. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:5 Topics: Adult; Arousal; Baroreflex; Death, Sudden, Cardiac; Electrocardiography; Female; Heart Rate; Humans; Male; Panic Disorder; Parasympathetic Nervous System; Paroxetine; Selective Serotonin Reuptake Inhibitors; Signal Processing, Computer-Assisted; Sympathetic Nervous System; Treatment Outcome	1997
Panic disorder induced by large doses of 3,4-methylenedioxymethamphetamine resolved by paroxetine. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:1 Topics: Adult; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	1998
Paroxetine and its uses in psychiatry. Hospital medicine (London, England : 1998), 1999, Volume: 60, Issue:5 Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Depression; Drug Interactions; Humans; Mental Disorders; Obsessive-Compulsive Disorder; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders	1999
Excretion of paroxetine into breast milk. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:8 Topics: Adult; Breast Feeding; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Humans; Lactation; Milk, Human; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Triglycerides	1999
Citalopram: new indication. No advantage. Prescrire international, 1999, Volume: 8, Issue:39 Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	1999
Galactorrhea after paroxetine treatment. Pharmacopsychiatry, 2000, Volume: 33, Issue:3 Topics: Adult; Agoraphobia; Antidepressive Agents, Second-Generation; Female; Galactorrhea; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	2000
Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder. Depression and anxiety, 2000, Volume: 11, Issue:3 Topics: Adult; Antidepressive Agents, Tricyclic; Death, Sudden, Cardiac; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Male; Nortriptyline; Panic Disorder; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors	2000
The effect of selective serotonin reuptake inhibitor treatment of panic disorder on emergency room and laboratory resource utilization. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:9 Topics: Adolescent; Adult; Cohort Studies; Cost Savings; Drug Costs; Emergency Service, Hospital; Female; Fluoxetine; Health Care Costs; Humans; Insurance Claim Review; Laboratories; Laboratories, Hospital; Male; Managed Care Programs; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	2001